Herein, we used data from the largest genome-wide association study (GWAS) to date on plasma BDNF levels, along with a statistical summary of seven common neurological disorders (AD, PD, ALS, MS, epilepsy, stroke, and migraine). This evidence concerns the gene BDNF and myeloid sarcoma.